NY-ESO-1-CONTAINING ARTIFICIAL ADJUVANT VECTOR CELL USED FOR TREATING CANCER Application EP-4071240-A4 European Patent Office 17 Jan 2024
THERAPEUTIC AGENT COMPRISING NUCLEIC ACID AND TCR MODIFIED IMMUNE CELL AND USE THEREOF Application EP-3842523-A4 European Patent Office 18 May 2022
VIRAL VECTORS ENCODING CANCER/TESTIS ANTIGENS FOR USE IN A METHOD OF PREVENTION OR… Application WO-2020025642-A1 World Intellectual Property Organisation (WIPO) 06 Feb 2020